Get notified when EZRA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Related Party (new) — Multiple related-party transactions where CEO and director hold 49% ownership in investment entity funded by company loans, creating potential conflicts around investment decisions and loan repayment.
Reliance Global forms healthcare investment unit with CEO, director as 49% owners
Filed May 4, 2026 · Period ending April 28, 2026 · ~1 min read
Key Changes
-
high
Company formed LifeSci Global Group LLC with 51% ownership; CEO Ezra Beyman and director Scott Korman own remaining 49% through related entity, creating significant related-party structure for healthcare investments.
Item 1.01 verify on EDGAR → -
high
Company provided $2M credit facility at 7% interest to fund LGG's investments; $500K advanced at closing. LGG made initial $2M investment in Innervate Radiopharmaceuticals, an early-stage radiopharmaceutical developer.
Item 1.01 verify on EDGAR → -
high
Director Scott Korman removed from all board committees (Audit, Compensation, Nominating) due to conflicts from LGG ownership and role as CEO of Innervate, the investment target.
Item 5.02 view on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade EZRA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify